<< Back To Article
Ocaliva Improves Liver Fibrosis in People With NASH

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*



This way of communicating (in the subtitle) is still limited: you write "about 1/4 of patients taking Ocaliva improve fibrosis". Indeed, but it is not 25%, but 23%, and above all to compare with the 12% of the placebo ... However, what many will remember is a fibrotic efficacy on 25% of the treated population while 'we are far from it ... we are closer to half of this figure, with in addition a significant non-resolution of NASH and an addition of statins in many cases which can also have a role

January 5, 2020


Hot topics